chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swollen arm; sore arm; bodyaches; redness; head ache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), PAIN IN EXTREMITY (sore arm), PAIN (bodyaches), ERYTHEMA (redness) and HEADACHE (head ache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PERIPHERAL SWELLING (swollen arm), PAIN IN EXTREMITY (sore arm), PAIN (bodyaches), ERYTHEMA (redness), HEADACHE (head ache), CHILLS (chills) and PYREXIA (fever). On 28-Feb-2021, PERIPHERAL SWELLING (swollen arm), PAIN (bodyaches), HEADACHE (head ache), CHILLS (chills) and PYREXIA (fever) had resolved. At the time of the report, PAIN IN EXTREMITY (sore arm) and ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
I started to feel achy in the early evening so I went to bed. At approximately 11:00 PM I woke up with an excruciating headache and joint pain all over my body. I felt nauseous if  I rolled over and at 1:00 AM decided the best course of action would be to try and vomit but ended up spitting up bile only. I went back to bed and my husband brought me flat ginger ale around 4:30 AM and saltine crackers of which I could only nibble the corner and sip a tiny bit. I ended up throwing  up what little I had eaten and drank, still having a sever headache and body aches. I felt better around 10:30 AM, 11 hours after the onset. I showered, ate 2 pieces of toast, had 1,000 mg of Tylenol and went back to bed and slept until around 3:00 PM. I woke up with no aches and just a slight headache and felt much better.  The next day approximately 20 hours after the injection, I woke up with just a slight headache and essentially felt 'fine'. I rarely get headaches so this may be why it felt so sever to me.
vomiting, weakness, coughing, fever, soe throat, chills, low blood pressure, pnemonia, sepsis
Inappropriate schedule of vaccine; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too short in a 76-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 16th October 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were received as follows: Wife calling on behalf of her husband reported that the patient received 2nd dose less than recommended interval, which led to shortening of vaccination schedule. He received the second dose in his left arm. The reporter consented to follow up.
general fatigue; soreness around the injection site; headache got increasingly worse, near the back of the head, which exacerbated her movement,; Shoulder pain; muscle aches; body aches; a really bad headache; nauseated; neck pain; neck muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (general fatigue), NECK PAIN (neck pain), MYALGIA (neck muscle pain), VACCINATION SITE PAIN (soreness around the injection site) and NAUSEA (nauseated) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced NECK PAIN (neck pain), MYALGIA (neck muscle pain) and NAUSEA (nauseated). On 07-May-2021, the patient experienced HEADACHE (a really bad headache). On 08-May-2021, the patient experienced MYALGIA (muscle aches) and PAIN (body aches). On an unknown date, the patient experienced FATIGUE (general fatigue), VACCINATION SITE PAIN (soreness around the injection site), HEADACHE (headache got increasingly worse, near the back of the head, which exacerbated her movement,) and ARTHRALGIA (Shoulder pain). On 09-May-2021, HEADACHE (a really bad headache) had resolved. At the time of the report, FATIGUE (general fatigue), NECK PAIN (neck pain), MYALGIA (neck muscle pain), VACCINATION SITE PAIN (soreness around the injection site), NAUSEA (nauseated), HEADACHE (headache got increasingly worse, near the back of the head, which exacerbated her movement,), ARTHRALGIA (Shoulder pain), MYALGIA (muscle aches) and PAIN (body aches) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
patient had right torso sensitivity starting 5/20/19 and broke out in shingles multiple dermatones 5/29/19
Patient had full Moderna vaccination on 1/20/2021 and 2/16/2021.  Was unable to have the lot numbers provided and was told that he needed to get another series because he didn't have the lot number.  Patient received 1 dose of Pfizer today.  Was able to educate readiness that they can go to the website and get confirmation.  Soldier will work with readiness and get this documented without the Lot numbers.
The second evening after having my 2nd Moderna dose my left arm completely froze up. I was only able to lift my arm above my head with assistance from my right arm. Eventually I was able to lift my arm without assistance and the same phenomena happened the third evening where my shoulder was frozen and immobilized.  The frozen shoulder has abated but there is still moving poi's of major swelling in the upper arm. There has been persistent but slowly abating symptoms of deep soreness, arm weakness and weak grip strength. Swelling persists in the upper front portion of left shoulder. I can not do extended tasks with the arm because it does not have strength nor stamina.
ALLERGY REVIEW OF SYSTEMS:  Patient denies fever, facial swelling, sore throat, frequent throat clearing, eyes watering, eyes itching, puffy eyes, eye redness, cough, chest tightness, shortness of breath, rash, hives, itching of skin, abdominal pain, muscle aches, dizziness and headaches    Pt sent a picture of herself to her son after getting her vaccine. Noted her R eye drooping. :     Previous Reactions: none    Objective    Vitals Vitals:   02/16/21 1535 02/16/21 1545 02/16/21 1555 BP: (!) 185/77 (!) 162/80 (!) 160/63 Pulse: 68     Resp: 16     SpO2: 98%            Physical Exam Vitals and nursing note reviewed.  Constitutional:      General: She is not in acute distress.    Appearance: She is not ill-appearing, toxic-appearing or diaphoretic.  HENT:     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: Oropharynx is clear.  Eyes:     General: Lids are normal.     Extraocular Movements: Extraocular movements intact.     Conjunctiva/sclera: Conjunctivae normal.     Pupils: Pupils are equal, round, and reactive to light.     Comments: Pt showed this provider picture she took of her R eye drooping. Picture demonstrates slight decrease in eye opening in comparison to L eye. Currently no eye drooping is noted.   Cardiovascular:     Rate and Rhythm: Normal rate.     Pulses: Normal pulses.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal.     Breath sounds: Normal breath sounds.  Musculoskeletal:     Right lower leg: No edema.     Left lower leg: No edema.  Skin:    General: Skin is warm.     Coloration: Skin is not pale.     Findings: No erythema.  Neurological:     General: No focal deficit present.     Mental Status: She is alert and oriented to person, place, and time.     Cranial Nerves: No cranial nerve deficit or facial asymmetry.     Sensory: Sensation is intact. No sensory deficit.     Motor: No weakness, tremor, abnormal muscle tone or pronator drift.     Coordination: Coordination is intact. Coordination normal.     Gait: Gait (steady gait with walker) normal.     Comments: Equal movement and strength +5/5 to upper and lower extremities.   Psychiatric:        Mood and Affect: Mood normal.        Behavior: Behavior normal.        Thought Content: Thought content normal.        Judgment: Judgment normal.     Comments: Slightly anxious affect.          Assessment/Plan  Treatment included: no therapy and reassurance Follow up response to treatment: good. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns)   Pt to follow up with pcp/new pcp if her bp at home continues to be elevated >140/90.  We discussed reasons to go to ED. She is stable today and is feeling good. She declined a wheelchair out to the front. She was wanting to walk with her walker. This provider walked out with her and her husband out to the front where they were met by their son. Pt did well on her ambulation without stopping. Pt and husband both voiced appreciation.    APRN Electronically Signed 2/16/2021 3:54 PM
Left clinic immediately after receiving vaccines, instead of waiting per instructions. Drove about 3 miles from clinic and had the feeling of throat closing. Returned to clinic.
I have been experiencing severe hives and body rash 3 days after my second Covid vaccination. I had no symptoms to my first dose.
Pt was given the vaccine and about 20 minutes later the pt fell in the parking lot and dislocated her right ring finger. EMT was called and she was taken to the ER.
Outdated Varivax given to pt on 9/3/03. Lot #0971L 1/7/03 (3 other patients this happened to as well).
experienced shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number AP257, expiry date 26th November 2021) for prophylaxis.   On 15th October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient experienced shingles. The reporter did not provide outcome or date of the adverse event The reporter requested information about the administration of the 2nd dose after the adverse event.  The reporter consented to follow up.
High fever, above 100 degrees; I am still tired and fatigued; This is a spontaneous report from a contactable consumer (Patient) via Pfizer-sponsored program. This is the parent case out of two cases.  A 58-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Batch/Lot Number: EN6207) via an unspecified route of administration on an unspecified date in 2021 (at the age of 58-year-old) as dose 1 single for COVID-19 immunisation. Medical history included deep vein thrombosis from an unspecified and unspecified if ongoing. Concomitant medication included apixaban (ELIQUIS) taken for deep vein thrombosis, start and stop date were not reported. On an unspecified date in 2021, patient had high fever, above 100 degrees. The patient received the first dose of the COVID vaccine (on Wednesday) and had a high fever. The patient had some side effects, fever above 100 degrees and he would like to know if those side effects are normal. The first day he felt fatigue and did not feel well. It was more like a fever and the fever did not get high but did not go over 101. It was 100.4 or 5 somewhere. It broke last night about 2 in the morning. At the time of report, he was still tired and fatigued but as the day went on felt better and better. The patient reported that the fever did away last night and was feeling much better at the time of report. The patient received treatment with Aspirin. The patient did not consider the event as serious. The clinical outcome of events was reported as recovering.  No follow-up attempts are possible. No further information is expected.
the patient did not experience any other AE; the patient received PEDVAXHIB after it experienced a temperature excursion; This spontaneous report was received from a consumer, referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant therapies were not provided.     On 19-NOV-2021, the patient was vaccinated with 1 dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot # t037648, expiration date 20-JUL-2023; strength, dose and route were not provided) for prophylaxis after it experienced a temperature excursion (product storage error). The patient did not experience any other adverse event (AE).        The vaccines were exposed to temperature excursion of 8.5 degree Celsius for 30 minutes. There was no previous temperature excursion. The digital data logger was involved.  This is one of several report from the same reporter.; Sender's Comments:  US-009507513-2112USA008421: US-009507513-2112USA008367:02080039
Saw reproductive endocrinologist.  Dx with acute autoimmune thyroiditis.  Started on Synthroid.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No pertinent medical history, drug reactions or allergies were reported. On 09-OCT-2014 the patient was vaccinated with an expired dose of ZOSTAVAX lot # J007211, expiration date 20-SEP-2014, 0.65 ml, subcutaneous (dose number was unspecified). No adverse effects reported. Concomitant therapies were not reported. The outcome of the events was unknown. Additional information has been requested.
Patient came into pharmacy as a walk-in patient for an M-M-R vaccination.  Technician entered vaccination under Menveo.  Patient filled out paperwork for meningitis vaccination.  Patient received Menveo vaccination instead of M-M-R vaccination.
Pfizer Covid Vaccine was given, 0.3ml, without diluant.  Spoke with Mom on 8/27/2021 and  is experiencing no adverse reactions at this time.  Mom had no questions or concerns.
pt recv vax 1DEC97 & devel myoclonic sz 21DEC97;hosp 25DEC-28DEC w/dx infantile spasms assoc w/ characteristic EEG hypsarrhythmia;sz have been uncontrolled despite med;severe delayed development;
I received the vaccine around 12:00pm. That evening I had severe chills and very bad chest pains. I also had body aches. The chest pains are the main thing I want to report. It lasted through the next day. I thought it was just me but my daughter's friend said the her friends mother also experience really bad chest pains the next day after her covid vaccine. Also, my husband just received a different covid vaccine and experienced chest pains. I thought it was worth reporting.  Several weeks later I received my second dose of Shingles vaccine and also experienced chest pains the next day. This didn't happen with the first dose. I thought maybe they have similar ingredients?
Patient received Fluzone HD vaccine and Pneumovax on 09/27 on the same arm. Patient came back to the pharmacy on  09/30 complaining of a rash and pain at the injection site. As per patient, pain started the day after immunization, but the rash only appeared in the morning of 09/29. Patient has no known allergies.
Pt came to the pharmacy on 11/17/22 and stated that 4 days after she received her Pfizer Bi-Valent Booster shot on 10/7/22 she got a red spot on the corner of her mouth. She stated that since then she has a terrible taste in her mouth, her lips stay dry and peel unless she keeps them moisturized and her lips feel "burned." She also stated the inside of her mouth and lips are swollen.  Also, she explained it burns the inside of her mouth when she drinks soda/pop.
Fever 102. Lethargy, unable to walk. large lump in thigh at injection sight.
Client pulled away on 1st attempt for vaccination, no vaccine injected. On 2nd successful attempt, needle was replaced and vaccine administered on opposite arm (Left deltoid) with mom's assistance in restraining the client. Unable to save client's correct age as of today, 6 yo, parent aware.
Fussiness, Tiredness, Vomiting, Rash, Redness, and swollen where shot was given and very poor appetite.
Shingles on face, worsening of condition of lichen sclerosus- valcyclovir, calmoseptine, clobetasol, halobetasol, nystatin, dexamethasone and triamcinolone injection,  seven injections of rocephin 1gm, clotrimazole cream. symptoms are now improving, some rash continues, worsening of existing condition
Before getting the third dose, they had some blood tests done and they showed low electrolytes.; Severe pain; Had red patch 4-6 inches long underneath injection site; Had a red swelling on the injection site; Lymph nodes were red under the shot; Fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Sep-2021 and was forwarded to Moderna on 09-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ELECTROLYTE IMBALANCE (Before getting the third dose, they had some blood tests done and they showed low electrolytes.), PAIN (Severe pain), RASH (Had red patch 4-6 inches long underneath injection site), INJECTION SITE SWELLING (Had a red swelling on the injection site) and INJECTION SITE LYMPHADENOPATHY (Lymph nodes were red under the shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A, 013A21A and 022C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ELECTROLYTE IMBALANCE (Before getting the third dose, they had some blood tests done and they showed low electrolytes.), PAIN (Severe pain), RASH (Had red patch 4-6 inches long underneath injection site), INJECTION SITE SWELLING (Had a red swelling on the injection site), INJECTION SITE LYMPHADENOPATHY (Lymph nodes were red under the shot) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 2 dosage form every six hours. At the time of the report, ELECTROLYTE IMBALANCE (Before getting the third dose, they had some blood tests done and they showed low electrolytes.), PAIN (Severe pain), RASH (Had red patch 4-6 inches long underneath injection site), INJECTION SITE SWELLING (Had a red swelling on the injection site), INJECTION SITE LYMPHADENOPATHY (Lymph nodes were red under the shot) and FATIGUE (Fatigue) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2021-314896 (Patient Link).
Weakness/loss of energy; Chills; Exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness/loss of energy), CHILLS (Chills) and FATIGUE (Exhaustion) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 016M20A) for COVID-19 vaccination.     No medical history provided by the reporter.  Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR), ESCITALOPRAM OXALATE (LEXAPRO) and FISH OIL (OMEGA 3 FISH OIL [FISH OIL]) for an unknown indication.   On 10-Mar-2001, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness/loss of energy), CHILLS (Chills) and FATIGUE (Exhaustion). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weakness/loss of energy), CHILLS (Chills) and FATIGUE (Exhaustion) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: inconclusive (Inconclusive) Blood work was fine. On an unknown date, Electrocardiogram: inconclusive (Inconclusive) EKG was fine.         Other concomitant products include Vitamins. Action taken with mRNA-1273 in response to the events is not applicable
PATIENT SAYS SHE IS EXPERIENCING FLAIR UPS OF SHINGLES BLISTERS ON HER FOREHEAD, SHOULDER, TRUNK AND LEGS. SAYS THEY FORMED BLISTERS AND SOME HAVE BROKEN OPEN AND ARE DRYING UP. SHE STATES THE SIGHTS ARE SWOLLEN AND PAINFUL.
Dizziness, sweaty, slept for up to 3 hours, redness at site of injection lasting in 5 minutes
Hives within 5 minutes, also tachycardia. Received BENADRYL and monitoring.
This is in follow-up to report(s) previously submitted on 7/10/2006; 9/1/2006. Information has been received from a physician concerning an 9 week old female, with no medical history and no allergies, who on 26-MAY-2006, in the am, was vaccinated with a first oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (Lot# 653661/0146F). Concomitant vaccines administered at the same time included a first intramuscular dose of PEDIARIX (Lot# AC21B0B3AA) and a first intramuscular dose of PREVNAR (Lot# 808641E). On 27-MAY-2006 the patient developed diarrhea.  At the time of the report the patient was fine, frequency was normal, but still had watery stools.  There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. No product quality complaint was involved. Follow-up information from a physician indicated that one day after receiving ROTATEQ, on 27-MAY-2006, the patient had loose stools, 2-3 times per day with the consistency of water until 10-JUN-2006. It was reported that from 11-JUN-2006 to 21-JUN-2006 the stools were watery once per day, and on 23-JUN-2006 the stools were watery twice per day. Follow-up information from a physician indicated that the patient's loose stools ended on approximately 26-JUN-2006. Additional informational is not expected.
Information has been received from a physician concerning a female (age not reported) who was vaccinated with a dose of Gardasil. The physician reported that "the patient was not pregnant but had miscarried three weeks prior" to vaccination. "Weeks of gestation was not known." The patient was seeing again by the physician on 07-JUN-2007. It was reported that two days after the patient received her dose of Gardasil, she was sent to the emergency room because she had developed a fever, leucopenia, and a lower platelet count of 80,000 (also reported as 86,000). The patient was treated with ciprofloxacin hydrochloride (CIPROFLOXACIN) and was sent home. The physician reported that "she has done well" but has a "big knot at the injection site, outer later quad in her leg (specific leg not specified)" which was "red before, no longer red now, just a knot, a fibrinous deposition there." The patient was told by her hematologist that "it was the vaccine and that this can happen in an immunization situation and not to take it again." The physician stated that "they need to find out what exactly caused this reaction in her." It was reported that "she has no other significant allergies but a family history of allergies, specifically a strong history of allergy to iodine dye used in radiology procedures." The patient "never wants to attempt any dye after all this." There was no product quality complaint. No further information is available.